Anti-Infectives; Oncology
HBM contact: Dr Ivo Staijen, Dr Emil Bujak
Company status: public
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories.